ME00934B - Upotreba 4-ciklopropilmetoksi-n-(3,5-dtiilor0-1-oksido-piridin-4-il)-5-(metoksi)-piridin-2-karboksamida za liječenje trauma kičmene moždine - Google Patents

Upotreba 4-ciklopropilmetoksi-n-(3,5-dtiilor0-1-oksido-piridin-4-il)-5-(metoksi)-piridin-2-karboksamida za liječenje trauma kičmene moždine

Info

Publication number
ME00934B
ME00934B MEP-2009-298A MEP29809A ME00934B ME 00934 B ME00934 B ME 00934B ME P29809 A MEP29809 A ME P29809A ME 00934 B ME00934 B ME 00934B
Authority
ME
Montenegro
Prior art keywords
cyclopropylmethoxy
carboxamide
dichloro
pyridine
methoxy
Prior art date
Application number
MEP-2009-298A
Other languages
English (en)
French (fr)
Inventor
Philippe Delay-Goyet
Badia Ferzaz
Jocelyne Lolivier
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of ME00934B publication Critical patent/ME00934B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Predmetni pronalazak se odnosi na upotrebu 4-ciklopropilmetoksi- N -( 3 , 5-dihloro-1- oksido-piridin-4-il)-5-(metoksi)- piridin-2-karboksamida   za dobijanje leka za lečenje trauma kičmene moždine.
MEP-2009-298A 2007-04-19 2008-04-16 Upotreba 4-ciklopropilmetoksi-n-(3,5-dtiilor0-1-oksido-piridin-4-il)-5-(metoksi)-piridin-2-karboksamida za liječenje trauma kičmene moždine ME00934B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0702851A FR2915098B1 (fr) 2007-04-19 2007-04-19 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere
PCT/FR2008/000533 WO2008145840A2 (fr) 2007-04-19 2008-04-16 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere

Publications (1)

Publication Number Publication Date
ME00934B true ME00934B (me) 2012-06-20

Family

ID=38779706

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2009-298A ME00934B (me) 2007-04-19 2008-04-16 Upotreba 4-ciklopropilmetoksi-n-(3,5-dtiilor0-1-oksido-piridin-4-il)-5-(metoksi)-piridin-2-karboksamida za liječenje trauma kičmene moždine

Country Status (33)

Country Link
US (1) US8592443B2 (me)
EP (1) EP2150253B1 (me)
JP (1) JP5386477B2 (me)
KR (1) KR101470043B1 (me)
CN (1) CN101674829B (me)
AR (1) AR066106A1 (me)
AT (1) ATE503481T1 (me)
AU (1) AU2008257321B2 (me)
BR (1) BRPI0810446A2 (me)
CA (1) CA2684172C (me)
CL (1) CL2008001134A1 (me)
CY (1) CY1111779T1 (me)
DE (1) DE602008005873D1 (me)
DK (1) DK2150253T3 (me)
EA (1) EA015355B1 (me)
ES (1) ES2363056T3 (me)
FR (1) FR2915098B1 (me)
HK (1) HK1142000A1 (me)
HR (1) HRP20110459T1 (me)
IL (1) IL201451A (me)
JO (1) JO2662B1 (me)
MA (1) MA31369B1 (me)
ME (1) ME00934B (me)
MX (1) MX2009011285A (me)
MY (1) MY146657A (me)
NZ (1) NZ580483A (me)
PA (1) PA8776601A1 (me)
PL (1) PL2150253T3 (me)
PT (1) PT2150253E (me)
SI (1) SI2150253T1 (me)
TW (1) TWI411435B (me)
UY (1) UY31033A1 (me)
WO (1) WO2008145840A2 (me)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2915099B1 (fr) 2007-04-19 2009-06-05 Sanofi Aventis Sa Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
MX2015006807A (es) * 2012-11-28 2016-01-14 Sanofi Sa Metodo de preparacion de formas cristalinas de la 4-(ciclopropilmetoxi)-n-(3,5-dicloro-1-oxidopiridin-4-il)-5-metox ipiridin-2-carboxamida y sus formas cristalinas.
WO2014083106A1 (en) * 2012-11-28 2014-06-05 Sanofi Process for preparing 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide
EP4281065A1 (en) 2021-01-20 2023-11-29 Alto Neuroscience, Inc. Enhancement of camp signaling as a combination drug strategy for the treatment of depression and related conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193926A (en) 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
ATE218549T1 (de) 1993-07-28 2002-06-15 Aventis Pharma Ltd Verbindungen als pde iv und tnf inhibitoren
GB9401460D0 (en) 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
GB9507297D0 (en) 1995-04-07 1995-05-31 Rh Ne Poulenc Rorer Limited New composition of matter
US6196968B1 (en) 1997-06-02 2001-03-06 General Surgical Innovations, Inc. Direct vision subcutaneous tissue retractor and method for use
US6177077B1 (en) * 1999-02-24 2001-01-23 Edward L. Tobinick TNT inhibitors for the treatment of neurological disorders
WO2001047915A1 (en) 1999-12-23 2001-07-05 Icos Corporation Cyclic amp-specific phosphodiesterase inhibitors
HUP0600103A2 (en) 2001-03-02 2006-06-28 Bristol Myers Squibb Co Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
WO2004005258A1 (en) 2002-07-02 2004-01-15 Merck Frosst Canada & Co. Di-aryl-substituted-ethane pyridone pde4 inhibitors
US20060083714A1 (en) 2003-01-27 2006-04-20 Warner James M Combination of a pde iv inhibitor and a tnf-alpha antagonist
JP2007525482A (ja) * 2003-10-07 2007-09-06 レノビス， インコーポレイテッド イオンチャネルリガンドとしてのアミド化合物およびその使用
AU2006257863A1 (en) * 2005-06-10 2006-12-21 F. Hoffmann-La Roche Ag Trisubstituted amines as phosphodiesterase 4 inhibitors
US20070021451A1 (en) * 2005-07-20 2007-01-25 Hamamatsu University School Of Medicine Method for preventing or treating neurologic damage after spinal cord injury

Also Published As

Publication number Publication date
US8592443B2 (en) 2013-11-26
JO2662B1 (en) 2012-06-17
MA31369B1 (fr) 2010-05-03
CY1111779T1 (el) 2015-10-07
DE602008005873D1 (de) 2011-05-12
JP2010524905A (ja) 2010-07-22
DK2150253T3 (da) 2011-07-25
EA200970969A1 (ru) 2010-02-26
MY146657A (en) 2012-09-14
PL2150253T3 (pl) 2011-08-31
KR101470043B1 (ko) 2014-12-05
CN101674829A (zh) 2010-03-17
MX2009011285A (es) 2009-11-02
US20100137370A1 (en) 2010-06-03
EP2150253B1 (fr) 2011-03-30
HK1142000A1 (me) 2010-11-26
ES2363056T3 (es) 2011-07-19
TW200911248A (en) 2009-03-16
KR20090130063A (ko) 2009-12-17
CN101674829B (zh) 2012-01-18
CA2684172C (fr) 2015-10-27
CL2008001134A1 (es) 2009-01-16
JP5386477B2 (ja) 2014-01-15
IL201451A (en) 2013-04-30
PT2150253E (pt) 2011-06-17
CA2684172A1 (fr) 2008-12-04
AR066106A1 (es) 2009-07-22
BRPI0810446A2 (pt) 2014-10-14
HRP20110459T1 (hr) 2011-07-31
NZ580483A (en) 2011-06-30
AU2008257321B2 (en) 2013-08-15
UY31033A1 (es) 2008-11-28
WO2008145840A3 (fr) 2009-06-25
WO2008145840A2 (fr) 2008-12-04
PA8776601A1 (es) 2008-11-19
SI2150253T1 (sl) 2011-07-29
AU2008257321A1 (en) 2008-12-04
TWI411435B (zh) 2013-10-11
IL201451A0 (en) 2010-05-31
EA015355B1 (ru) 2011-06-30
FR2915098B1 (fr) 2009-06-05
ATE503481T1 (de) 2011-04-15
FR2915098A1 (fr) 2008-10-24
EP2150253A2 (fr) 2010-02-10

Similar Documents

Publication Publication Date Title
MX2009012066A (es) Imidazopirinas sustituidas como inhibidoras de cinasa de lipido p13k.
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
CY1112429T1 (el) Υποκατεστημενα παραγωγα σουλφοναμιδιου
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
EA200970913A1 (ru) 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
WO2009016410A3 (en) Chemical compounds 831
MX2009004623A (es) Imidazopiridazinas como inhibidores de la lipido cinasa pi3k.
MX2010013682A (es) Derivados de 2,4-diamino-l,3,5-triazina triciclicos utiles para el tratamiento del cancer y trastornos mieloproliferativos.
AU2007249926A8 (en) Monocyclic heteroaryl compounds
MX342947B (es) Tratamiento de diabetes tipo 2.
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
TW200738627A (en) Trialkylsilyl-indoles
MX2012007896A (es) Derivados de piridino-piridinonas arilsulfonamidas, su preparacion y su uso en terapeutica.
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
ME00934B (me) Upotreba 4-ciklopropilmetoksi-n-(3,5-dtiilor0-1-oksido-piridin-4-il)-5-(metoksi)-piridin-2-karboksamida za liječenje trauma kičmene moždine
MX2010002007A (es) Sulfonas ciclicas sustituidas por amino-bencilo utiles como inhibidores de bace.
TW200800993A (en) Organic compounds
GB0609897D0 (en) Compounds
WO2009027736A3 (en) 2,4 diaminopyrimid'lnes for the treatment of myeloproliferative disorders and cancer
MX2010005545A (es) Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca.
EA200801678A1 (ru) Применение производных триазина для производства лекарственного средства, обладающего заживляющим или ангиогенным эффектом
ME00935B (me) Upotreba 4-ciklopropilmetoksi-<i>n</i>-(3,5-dihlor0-1- 0ksido- piridin-4-il)-5-(metoksi)piridin-2- karboksamida za liječenje motoričkih poremećaja povezanih sa parkinsonovom bolešću
MX2009012683A (es) Benzamidas utiles como moduladores del receptor s1p.
MX2011011180A (es) Compuestos que tienen efecto fisiologico.